Publications by authors named "M Sabet"

Despite significant advancements in gene delivery and CRISPR technology, several challenges remain. Chief among these are overcoming serum inhibition and achieving high transfection efficiency with minimal cytotoxicity. To address these issues, there is a need for novel vectors that exhibit lower toxicity, maintain stability in serum-rich environments, and effectively deliver plasmids of various sizes across diverse cell types.

View Article and Find Full Text PDF

Artificial Intelligence (AI) based auto-segmentation has demonstrated numerous benefits to clinical radiotherapy workflows. However, the rapidly changing regulatory, research, and market environment presents challenges around selecting and evaluating the most suitable solution. To support the clinical adoption of AI auto-segmentation systems, Selection Criteria recommendations were developed to enable a holistic evaluation of vendors, considering not only raw performance but associated risks uniquely related to the clinical deployment of AI.

View Article and Find Full Text PDF

Solid-state lithium-sulfur (Li-S) batteries show promise for future electric mobility due to their high energy density potential. However, high internal impedance, Li polysulfide shuttling, and dendrite formation exist. Herein, we present a Li-rich cellulosic solid-state electrolyte (SSE) that, when paired with a sulfurized polyacrylonitrile (SPAN) cathode, leads to durable Li-S batteries for use in the room temperature to 50 °C range.

View Article and Find Full Text PDF

Declines in older adults' cognitive and physical health pose challenges to maintaining their independence. Robots can improve independent living and facilitate aging-in-place. Despite recent innovations in healthcare robotics, the use of robots has not advanced significantly among older adults.

View Article and Find Full Text PDF
Article Synopsis
  • The meta-analysis compares long-term outcomes of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in low-surgical risk patients with severe aortic stenosis.
  • TAVR showed lower all-cause mortality risk within 30 days and up to one year compared to SAVR, but risks were similar after one year.
  • Additionally, TAVR had lower rates of cardiovascular mortality, disabling strokes, rehospitalizations, and new-onset atrial fibrillation, but a higher chance of needing a permanent pacemaker, especially in the first 30 days.
View Article and Find Full Text PDF